ABT

NYSE

ABBOTT LABORATORIES

Latest disclosureOctober 2, 2026

Insider score Why 23?: 23/ 100
Qualifying buys · 30d: $0

3 purchases · 4 sales

Price by TradingView

Insider transactions 49

Limited filing history

Filters

Last 30 daysNo qualifying insider buying. No qualifying insider sales.

Showing the first 6 of 49 trades on this page.

Award disclosed

John G. Stratton

Director

Stock Equivalent Units

Derivative security · not the ordinary share price.

Value context: $39.24K
Reported price: $98.83 / derivative unit

Award disclosed

Patricia Paola Gonzalez

Director

Stock Equivalent Units

Derivative security · not the ordinary share price.

Value context: $32.91K
Reported price: $98.83 / derivative unit

Award disclosed

Kevin T. Conroy

Director

Stock Equivalent Units

Derivative security · not the ordinary share price.

Value context: $31.43K
Reported price: $98.83 / derivative unit

Award disclosed

Nita Ahuja

Director

Stock Equivalent Units

Derivative security · not the ordinary share price.

Value context: $31.43K
Reported price: $98.83 / derivative unit

Award disclosed

Michael F. Roman

Director

Stock Equivalent Units

Derivative security · not the ordinary share price.

Value context: $37.65K
Reported price: $98.83 / derivative unit

Tax or exercise withholding

Kevin T. Conroy

Director

Common shares without par value

Value context: $5.46M
Reported price: $103.99 / share

Tax or exercise withholding

John A. Mccoy Jr.

VICE PRESIDENT AND CONTROLLER

Common shares without par value

Value context: $5.74K
Reported price: $110.36 / share

Sale disclosed

John A. Mccoy Jr.

VICE PRESIDENT AND CONTROLLER

Common shares without par value

Reported value: $2.96K
Reported price: $109.54 / share

Tax or exercise withholding

Philip P. Boudreau

EVP AND CFO

Common shares without par value

Value context: $42.82K
Reported price: $110.36 / share

Exercise or conversion

Robert B. Ford

CHAIRMAN AND CEO

Common shares without par value

Value context: $6.74M
Reported price: $44.40 / share

Exercise or conversion

Robert B. Ford

CHAIRMAN AND CEO

Common shares without par value

Value context: $14.8M
Reported price: $59.94 / share

Sale disclosed

Robert B. Ford

CHAIRMAN AND CEO

Common shares without par value

Reported value: $25.26M
Reported price: $115.57 / share

Sale disclosed

Robert B. Ford

CHAIRMAN AND CEO

Common shares without par value

Reported value: $20.95M
Reported price: $116.19 / share

Exercise or conversion

Robert B. Ford

CHAIRMAN AND CEO

Option (right to buy)

Derivative security · not the ordinary share price.

Value context: Not a separate purchase
Exercise / conversion price: $44.40 exercise / conversion price

Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Exercise or conversion

Robert B. Ford

CHAIRMAN AND CEO

Option (right to buy)

Derivative security · not the ordinary share price.

Value context: Not a separate purchase
Exercise / conversion price: $59.94 exercise / conversion price

Understand this price

Sale disclosed

Louis H. Morrone

EXECUTIVE VICE PRESIDENT

Common shares without par value

Reported value: $642.51K
Reported price: $109.83 / share

Other activity disclosed

Louis H. Morrone

EXECUTIVE VICE PRESIDENT

Common shares without par value

Value context: $1.3K
Reported price: $107.99 / share

Award disclosed

John G. Stratton

Director

Stock Equivalent Units

Derivative security · not the ordinary share price.

Value context: $39.2K
Reported price: $90.74 / derivative unit

Award disclosed

Michael F. Roman

Director

Stock Equivalent Units

Derivative security · not the ordinary share price.

Value context: $37.75K
Reported price: $90.74 / derivative unit

Award disclosed

Patricia Paola Gonzalez

Director

Stock Equivalent Units

Derivative security · not the ordinary share price.

Value context: $32.94K
Reported price: $90.74 / derivative unit

Award disclosed

Kevin T. Conroy

Director

Stock Equivalent Units

Derivative security · not the ordinary share price.

Value context: $20.96K
Reported price: $90.74 / derivative unit

Award disclosed

Nita Ahuja

Director

Stock Equivalent Units

Derivative security · not the ordinary share price.

Value context: $31.49K
Reported price: $90.74 / derivative unit

Tax or exercise withholding

Louis H. Morrone

EXECUTIVE VICE PRESIDENT

Common shares without par value

Value context: $24.94K
Reported price: $92.71 / share

Tax or exercise withholding

Elizabeth C. Cushman

EVP, GC AND SECRETARY

Common shares without par value

Value context: $52.71K
Reported price: $94.12 / share

Purchase disclosed

John G. Stratton

Director

Common shares without par value

Reported value: $173.64K
Reported price: $86.82 / share

Other activity disclosed

Mary K. Moreland

EXECUTIVE VICE PRESIDENT

Common shares without par value

Value context: $501.69K
Reported price: $94.41 / share

Award disclosed

Kevin T. Conroy

Director

Common shares without par value

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

John G. Stratton

Director

Common shares without par value

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Daniel J. Starks

Director

Common shares without par value

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Purchase disclosed

Daniel J. Starks

Director

Common shares without par value

Reported value: $926.54K
Reported price: $92.6537 / share

Award disclosed

Daniel J. Starks

Director

Option (right to buy)

Derivative security · not the ordinary share price.

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Michael F. Roman

Director

Common shares without par value

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Michael O.'Grady

Director

Common shares without par value

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Michael O.'Grady

Director

Option (right to buy)

Derivative security · not the ordinary share price.

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Nancy McKinstry

Director

Common shares without par value

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Nancy McKinstry

Director

Option (right to buy)

Derivative security · not the ordinary share price.

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Darren W. McDew

Director

Common shares without par value

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Michelle Kumbier

Director

Common shares without par value

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Patricia Paola Gonzalez

Director

Common shares without par value

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Sally E. Blount

Director

Common shares without par value

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Claire Babineaux-Fontenot

Director

Common shares without par value

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Nita Ahuja

Director

Common shares without par value

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Other activity disclosed

Philip P. Boudreau

EVP AND CFO

Common shares without par value

Value context: $819.98K
Reported price: $92.04 / share

Purchase disclosed

Philip P. Boudreau

EVP AND CFO

Common shares without par value

Reported value: $201.3K
Reported price: $91.50 / share

Award disclosed

John G. Stratton

Director

Stock Equivalent Units

Derivative security · not the ordinary share price.

Value context: $39.22K
Reported price: $102.67 / derivative unit

Award disclosed

Michael F. Roman

Director

Stock Equivalent Units

Derivative security · not the ordinary share price.

Value context: $37.68K
Reported price: $102.67 / derivative unit

Award disclosed

Patricia Paola Gonzalez

Director

Stock Equivalent Units

Derivative security · not the ordinary share price.

Value context: $32.96K
Reported price: $102.67 / derivative unit

Award disclosed

Robert J. Alpern

Director

Stock Equivalent Units

Derivative security · not the ordinary share price.

Value context: $7.8K
Reported price: $102.67 / derivative unit

Award disclosed

Nita Ahuja

Director

Stock Equivalent Units

Derivative security · not the ordinary share price.

Value context: $10.47K
Reported price: $102.67 / derivative unit

Reporting insider	Security / transaction	Amount / price	Value	Traded / disclosed	Source
Director	Stock Equivalent UnitsGrant or award	Derivative units397$98.83 / derivative unit	$39.24K	Sep 30Filed Oct 2 · 2d later	SEC filing
Director	Stock Equivalent UnitsGrant or award	Derivative units333$98.83 / derivative unit	$32.91K	Sep 30Filed Oct 2 · 2d later	SEC filing
Director	Stock Equivalent UnitsGrant or award	Derivative units318$98.83 / derivative unit	$31.43K	Sep 30Filed Oct 2 · 2d later	SEC filing
Director	Stock Equivalent UnitsGrant or award	Derivative units318$98.83 / derivative unit	$31.43K	Sep 30Filed Oct 2 · 2d later	SEC filing
Director	Stock Equivalent UnitsGrant or award	Derivative units381$98.83 / derivative unit	$37.65K	Sep 30Filed Oct 2 · 2d later	SEC filing
Director	Common shares without par valueExercise-price or tax withholding	52,507$103.99 / share	$5.46M	Sep 23Filed Sep 25 · 2d later	SEC filing
VICE PRESIDENT AND CONTROLLER	Common shares without par valueExercise-price or tax withholding	52$110.36 / share	$5.74K	Sep 1Filed Sep 3 · 2d later	SEC filing
VICE PRESIDENT AND CONTROLLER	Common shares without par valueSale	27$109.54 / share	$2.96K	Sep 2Filed Sep 3 · 1d later	SEC filing
EVP AND CFO	Common shares without par valueExercise-price or tax withholding	388$110.36 / share	$42.82K	Sep 1Filed Sep 3 · 2d later	SEC filing
CHAIRMAN AND CEO	Common shares without par valueOption exercise or conversion	151,869$44.40 / share	$6.74M	Aug 25Filed Aug 27 · 2d later	SEC filing
CHAIRMAN AND CEO	Common shares without par valueOption exercise or conversion	246,963$59.94 / share	$14.8M	Aug 25Filed Aug 27 · 2d later	SEC filing
CHAIRMAN AND CEO	Common shares without par valueSale2 trades	398,832avg $115.85 / share	$46.2M	Aug 25Filed Aug 27 · 2d later	2 filings 218,535 @ $115.57 · $25.26MSEC filing 180,297 @ $116.19 · $20.95MSEC filing
CHAIRMAN AND CEO	Option (right to buy)Option exercise or conversion	Derivative units151,869$44.40 exercise / conversion price	Not a separate purchase	Aug 25Filed Aug 27 · 2d later	SEC filing
CHAIRMAN AND CEO	Option (right to buy)Option exercise or conversion	Derivative units246,963$59.94 exercise / conversion price	Not a separate purchase	Aug 25Filed Aug 27 · 2d later	SEC filing
EXECUTIVE VICE PRESIDENT	Common shares without par valueSale	5,850$109.83 / share	$642.51K	Aug 11Filed Aug 13 · 2d later	SEC filing
EXECUTIVE VICE PRESIDENT	Common shares without par valueDiscretionary transaction	12$107.99 / share	$1.3K	Aug 12Filed Aug 13 · 1d later	SEC filing
Director	Stock Equivalent UnitsGrant or award	Derivative units432$90.74 / derivative unit	$39.2K	Jun 30Filed Jul 1 · 1d later	SEC filing
Director	Stock Equivalent UnitsGrant or award	Derivative units416$90.74 / derivative unit	$37.75K	Jun 30Filed Jul 1 · 1d later	SEC filing
Director	Stock Equivalent UnitsGrant or award	Derivative units363$90.74 / derivative unit	$32.94K	Jun 30Filed Jul 1 · 1d later	SEC filing
Director	Stock Equivalent UnitsGrant or award	Derivative units231$90.74 / derivative unit	$20.96K	Jun 30Filed Jul 1 · 1d later	SEC filing
Director	Stock Equivalent UnitsGrant or award	Derivative units347$90.74 / derivative unit	$31.49K	Jun 30Filed Jul 1 · 1d later	SEC filing
EXECUTIVE VICE PRESIDENT	Common shares without par valueExercise-price or tax withholding	269$92.71 / share	$24.94K	Jun 30Filed Jul 1 · 1d later	SEC filing
EVP, GC AND SECRETARY	Common shares without par valueExercise-price or tax withholding	560$94.12 / share	$52.71K	Jun 27Filed Jun 29 · 2d later	SEC filing
Director	Common shares without par valuePurchase	2,000$86.82 / share	$173.64K	May 7Filed Jun 18 · 42d later	SEC filing
EXECUTIVE VICE PRESIDENT	Common shares without par valueDiscretionary transaction	5,314$94.41 / share	$501.69K	Apr 28Filed Apr 29 · 1d later	SEC filing
Director	Common shares without par valueGrant or award	2,286Award · no purchase price	Non-cash award	Apr 24Filed Apr 28 · 4d later	SEC filing
Director	Common shares without par valueGrant or award	2,286Award · no purchase price	Non-cash award	Apr 24Filed Apr 28 · 4d later	SEC filing
Director	Common shares without par valueGrant or award	2,286Award · no purchase price	Non-cash award	Apr 24Filed Apr 28 · 4d later	SEC filing
Director	Common shares without par valuePurchase	10,000$92.65 / share	$926.54K	Apr 27Filed Apr 28 · 1d later	SEC filing
Director	Option (right to buy)Grant or award	Derivative units7,105Award · no purchase price	Non-cash award	Apr 24Filed Apr 28 · 4d later	SEC filing
Director	Common shares without par valueGrant or award	2,286Award · no purchase price	Non-cash award	Apr 24Filed Apr 28 · 4d later	SEC filing
Director	Common shares without par valueGrant or award	2,286Award · no purchase price	Non-cash award	Apr 24Filed Apr 28 · 4d later	SEC filing
Director	Option (right to buy)Grant or award	Derivative units5,929Award · no purchase price	Non-cash award	Apr 24Filed Apr 28 · 4d later	SEC filing
Director	Common shares without par valueGrant or award	2,286Award · no purchase price	Non-cash award	Apr 24Filed Apr 28 · 4d later	SEC filing
Director	Option (right to buy)Grant or award	Derivative units2,305Award · no purchase price	Non-cash award	Apr 24Filed Apr 28 · 4d later	SEC filing
Director	Common shares without par valueGrant or award	2,286Award · no purchase price	Non-cash award	Apr 24Filed Apr 28 · 4d later	SEC filing
Director	Common shares without par valueGrant or award	2,286Award · no purchase price	Non-cash award	Apr 24Filed Apr 28 · 4d later	SEC filing
Director	Common shares without par valueGrant or award	2,286Award · no purchase price	Non-cash award	Apr 24Filed Apr 28 · 4d later	SEC filing
Director	Common shares without par valueGrant or award	2,286Award · no purchase price	Non-cash award	Apr 24Filed Apr 28 · 4d later	SEC filing
Director	Common shares without par valueGrant or award	2,286Award · no purchase price	Non-cash award	Apr 24Filed Apr 28 · 4d later	SEC filing
Director	Common shares without par valueGrant or award	2,286Award · no purchase price	Non-cash award	Apr 24Filed Apr 28 · 4d later	SEC filing
EVP AND CFO	Common shares without par valueDiscretionary transaction	8,909$92.04 / share	$819.98K	Apr 23Filed Apr 27 · 4d later	SEC filing
EVP AND CFO	Common shares without par valuePurchase	2,200$91.50 / share	$201.3K	Apr 23Filed Apr 27 · 4d later	SEC filing
Director	Stock Equivalent UnitsGrant or award	Derivative units382$102.67 / derivative unit	$39.22K	Mar 31Filed Apr 2 · 2d later	SEC filing
Director	Stock Equivalent UnitsGrant or award	Derivative units367$102.67 / derivative unit	$37.68K	Mar 31Filed Apr 2 · 2d later	SEC filing
Director	Stock Equivalent UnitsGrant or award	Derivative units321$102.67 / derivative unit	$32.96K	Mar 31Filed Apr 2 · 2d later	SEC filing
Director	Stock Equivalent UnitsGrant or award	Derivative units76$102.67 / derivative unit	$7.8K	Mar 31Filed Apr 2 · 2d later	SEC filing
Director	Stock Equivalent UnitsGrant or award	Derivative units102$102.67 / derivative unit	$10.47K	Mar 31Filed Apr 2 · 2d later	SEC filing

Congress transactions 26

All Congress filings

Sale disclosed

Abbott Laboratories Common Stock (ABT) · Stock

The filing reports a sale for a spouse.

Richard W. AllenReporting House member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: July 14, 2026

Sale disclosed

Abbott Laboratories Common Stock (ABT) · Stock

The filing reports a sale for the member.

Richard Dean Dr McCormick official portrait

Richard Dean Dr McCormickReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: July 30, 2026

Sale disclosed

Abbott Laboratories Common Stock (ABT) · Stock

The filing reports a sale for a spouse.

Mike KellyReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: July 17, 2026

Full sale disclosed

Abbott Laboratories Common Stock · Stock

The filing reports a full sale for the member.

AAAlan ArmstrongReporting Senate member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: March 27, 2026

Sale disclosed

Abbott Laboratories Common Stock (ABT) · Stock

The filing reports a sale for the member.

Rick LarsenReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: July 8, 2026

Purchase disclosed

Abbott Laboratories Common Stock (ABT) · Stock

The filing reports a purchase for the member.

Richard Dean Dr McCormickReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: June 12, 2026

Purchase disclosed

Abbott Laboratories Common Stock (ABT) · Stock

The filing reports a purchase for the member.

Richard Dean Dr McCormickReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: June 12, 2026

Purchase disclosed

Abbott Laboratories Common Stock (ABT) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: June 16, 2026

Sale disclosed

Abbott Laboratories Common Stock (ABT) · Stock

The filing reports a sale for a joint account.

Julie JohnsonReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: May 12, 2026

Sale disclosed

Abbott Laboratories Common Stock (ABT) · Stock

The filing reports a sale for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: May 15, 2026

Sale disclosed

Abbott Laboratories Common Stock (ABT) · Stock

The filing reports a sale for a spouse.

Richard W. AllenReporting House member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: April 16, 2026

Partial sale disclosed

Abbott Laboratories Common Stock (ABT) · Stock

The filing reports a partial sale for a joint account.

Josh GottheimerReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: May 27, 2026

Exchange disclosed

Abbott Laboratories Common Stock (ABT) · Stock

The filing reports an exchange for the member.

Laura FriedmanReporting House member

Reported amount: $1,001 – $15,000Reported exchange amount; not a valuation of shares received.
Trade date: March 24, 2026

Purchase disclosed

Abbott Laboratories Common Stock (ABT) · Stock

The filing reports a purchase for the member.

Richard Dean Dr McCormickReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: March 19, 2026

Partial sale disclosed

Abbott Laboratories Common Stock (ABT) · Stock

The filing reports a partial sale for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: February 10, 2026

Purchase disclosed

Abbott Laboratories Common Stock (ABT) · Stock

The filing reports a purchase for the member.

Thomas H. Kean JrReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: January 29, 2026

Sale disclosed

Abbott Laboratories Common Stock (ABT) · Stock

The filing reports a sale for a joint account.

Julie JohnsonReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 18, 2025

Sale disclosed

Abbott Laboratories Common Stock (ABT) · Stock

The filing reports a sale for the member.

Julia LetlowReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 8, 2025

Purchase disclosed

Abbott Laboratories Common Stock (ABT) · Stock

The filing reports a purchase for the member.

Julia LetlowReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 23, 2024

Partial sale disclosed

Abbott Laboratories Common Stock (ABT) · Stock

The filing reports a partial sale for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 19, 2025

Sale disclosed

Abbott Laboratories Common Stock (ABT) · Stock

The filing reports a sale for the member.

Byron DonaldsReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 4, 2025

Sale disclosed

Abbott Laboratories Common Stock (ABT) · Stock

The filing reports a sale for a spouse.

Byron DonaldsReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 4, 2025

Purchase disclosed

Abbott Laboratories Common Stock (ABT) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: November 18, 2025

Partial sale disclosed

Abbott Laboratories Common Stock (ABT) · Stock

The filing reports a partial sale for a joint account.

Julie JohnsonReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: November 13, 2025

Purchase disclosed

Abbott Laboratories Common Stock (ABT) · Stock

The filing reports a purchase for the member.

Richard Dean Dr McCormickReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: November 5, 2025

Showing the latest 25 of 26 disclosed trades. Show all 26 trades

Why this buying score?

Qualifying common-equity purchase value

$325,369 of common-equity purchase value after transaction-age decay across 180 days.

+12 pts

Distinct buying groups

3 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.

+5 pts

CFO purchase

Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.

+3 pts

Material reported holdings increase

At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.

+3 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0000001800
Latest public acceptance: Oct 2, 2026, 08:11 PM UTC
Score calculated: Oct 8, 2026, 12:02 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.

Reporting insider

Security / transaction

Amount / price

Value

Traded / disclosed

Source

Director

Stock Equivalent UnitsGrant or award

Derivative units397$98.83 / derivative unit

$39.24K

Sep 30Filed Oct 2 · 2d later

SEC filing

Director

Stock Equivalent UnitsGrant or award

Derivative units333$98.83 / derivative unit

$32.91K

Sep 30Filed Oct 2 · 2d later

SEC filing

Director

Stock Equivalent UnitsGrant or award

Derivative units318$98.83 / derivative unit

$31.43K

Sep 30Filed Oct 2 · 2d later

SEC filing

Director

Stock Equivalent UnitsGrant or award

Derivative units318$98.83 / derivative unit

$31.43K

Sep 30Filed Oct 2 · 2d later

SEC filing

Director

Stock Equivalent UnitsGrant or award

Derivative units381$98.83 / derivative unit

$37.65K

Sep 30Filed Oct 2 · 2d later

SEC filing

Director

Common shares without par valueExercise-price or tax withholding

52,507$103.99 / share

$5.46M

Sep 23Filed Sep 25 · 2d later

SEC filing

VICE PRESIDENT AND CONTROLLER

Common shares without par valueExercise-price or tax withholding

52$110.36 / share

$5.74K

Sep 1Filed Sep 3 · 2d later

SEC filing

VICE PRESIDENT AND CONTROLLER

Common shares without par valueSale

27$109.54 / share

$2.96K

Sep 2Filed Sep 3 · 1d later

SEC filing

EVP AND CFO

Common shares without par valueExercise-price or tax withholding

388$110.36 / share

$42.82K

Sep 1Filed Sep 3 · 2d later

SEC filing

CHAIRMAN AND CEO

Common shares without par valueOption exercise or conversion

151,869$44.40 / share

$6.74M

Aug 25Filed Aug 27 · 2d later

SEC filing

CHAIRMAN AND CEO

Common shares without par valueOption exercise or conversion

246,963$59.94 / share

$14.8M

Aug 25Filed Aug 27 · 2d later

SEC filing

CHAIRMAN AND CEO

Common shares without par valueSale2 trades

398,832avg $115.85 / share

$46.2M

Aug 25Filed Aug 27 · 2d later

2 filings

218,535 @ $115.57 · $25.26MSEC filing
180,297 @ $116.19 · $20.95MSEC filing

CHAIRMAN AND CEO

Option (right to buy)Option exercise or conversion

Derivative units151,869$44.40 exercise / conversion price

Not a separate purchase

Aug 25Filed Aug 27 · 2d later

SEC filing

CHAIRMAN AND CEO

Option (right to buy)Option exercise or conversion

Derivative units246,963$59.94 exercise / conversion price

Not a separate purchase

Aug 25Filed Aug 27 · 2d later

SEC filing

EXECUTIVE VICE PRESIDENT

Common shares without par valueSale

5,850$109.83 / share

$642.51K

Aug 11Filed Aug 13 · 2d later

SEC filing

EXECUTIVE VICE PRESIDENT

Common shares without par valueDiscretionary transaction

12$107.99 / share

$1.3K

Aug 12Filed Aug 13 · 1d later

SEC filing

Director

Stock Equivalent UnitsGrant or award

Derivative units432$90.74 / derivative unit

$39.2K

Jun 30Filed Jul 1 · 1d later

SEC filing

Director

Stock Equivalent UnitsGrant or award

Derivative units416$90.74 / derivative unit

$37.75K

Jun 30Filed Jul 1 · 1d later

SEC filing

Director

Stock Equivalent UnitsGrant or award

Derivative units363$90.74 / derivative unit

$32.94K

Jun 30Filed Jul 1 · 1d later

SEC filing

Director

Stock Equivalent UnitsGrant or award

Derivative units231$90.74 / derivative unit

$20.96K

Jun 30Filed Jul 1 · 1d later

SEC filing

Director

Stock Equivalent UnitsGrant or award

Derivative units347$90.74 / derivative unit

$31.49K

Jun 30Filed Jul 1 · 1d later

SEC filing

EXECUTIVE VICE PRESIDENT

Common shares without par valueExercise-price or tax withholding

269$92.71 / share

$24.94K

Jun 30Filed Jul 1 · 1d later

SEC filing

EVP, GC AND SECRETARY

Common shares without par valueExercise-price or tax withholding

560$94.12 / share

$52.71K

Jun 27Filed Jun 29 · 2d later

SEC filing

Director

Common shares without par valuePurchase

2,000$86.82 / share

$173.64K

May 7Filed Jun 18 · 42d later

SEC filing

EXECUTIVE VICE PRESIDENT

Common shares without par valueDiscretionary transaction

5,314$94.41 / share

$501.69K

Apr 28Filed Apr 29 · 1d later

SEC filing

Director

Common shares without par valueGrant or award

2,286Award · no purchase price

Non-cash award

Apr 24Filed Apr 28 · 4d later

SEC filing

Director

Common shares without par valueGrant or award

2,286Award · no purchase price

Non-cash award

Apr 24Filed Apr 28 · 4d later

SEC filing

Director

Common shares without par valueGrant or award

2,286Award · no purchase price

Non-cash award

Apr 24Filed Apr 28 · 4d later

SEC filing

Director

Common shares without par valuePurchase

10,000$92.65 / share

$926.54K

Apr 27Filed Apr 28 · 1d later

SEC filing

Director

Option (right to buy)Grant or award

Derivative units7,105Award · no purchase price

Non-cash award

Apr 24Filed Apr 28 · 4d later

SEC filing

Director

Common shares without par valueGrant or award

2,286Award · no purchase price

Non-cash award

Apr 24Filed Apr 28 · 4d later

SEC filing

Director

Common shares without par valueGrant or award

2,286Award · no purchase price

Non-cash award

Apr 24Filed Apr 28 · 4d later

SEC filing

Director

Option (right to buy)Grant or award

Derivative units5,929Award · no purchase price

Non-cash award

Apr 24Filed Apr 28 · 4d later

SEC filing

Director

Common shares without par valueGrant or award

2,286Award · no purchase price

Non-cash award

Apr 24Filed Apr 28 · 4d later

SEC filing

Director

Option (right to buy)Grant or award

Derivative units2,305Award · no purchase price

Non-cash award

Apr 24Filed Apr 28 · 4d later

SEC filing

Director

Common shares without par valueGrant or award

2,286Award · no purchase price

Non-cash award

Apr 24Filed Apr 28 · 4d later

SEC filing

Director

Common shares without par valueGrant or award

2,286Award · no purchase price

Non-cash award

Apr 24Filed Apr 28 · 4d later

SEC filing

Director

Common shares without par valueGrant or award

2,286Award · no purchase price

Non-cash award

Apr 24Filed Apr 28 · 4d later

SEC filing

Director

Common shares without par valueGrant or award

2,286Award · no purchase price

Non-cash award

Apr 24Filed Apr 28 · 4d later

SEC filing

Director

Common shares without par valueGrant or award

2,286Award · no purchase price

Non-cash award

Apr 24Filed Apr 28 · 4d later

SEC filing

Director

Common shares without par valueGrant or award

2,286Award · no purchase price

Non-cash award

Apr 24Filed Apr 28 · 4d later

SEC filing

EVP AND CFO

Common shares without par valueDiscretionary transaction

8,909$92.04 / share

$819.98K

Apr 23Filed Apr 27 · 4d later

SEC filing

EVP AND CFO

Common shares without par valuePurchase

2,200$91.50 / share

$201.3K

Apr 23Filed Apr 27 · 4d later

SEC filing

Director

Stock Equivalent UnitsGrant or award

Derivative units382$102.67 / derivative unit

$39.22K

Mar 31Filed Apr 2 · 2d later

SEC filing

Director

Stock Equivalent UnitsGrant or award

Derivative units367$102.67 / derivative unit

$37.68K

Mar 31Filed Apr 2 · 2d later

SEC filing

Director

Stock Equivalent UnitsGrant or award

Derivative units321$102.67 / derivative unit

$32.96K

Mar 31Filed Apr 2 · 2d later

SEC filing

Director

Stock Equivalent UnitsGrant or award

Derivative units76$102.67 / derivative unit

$7.8K

Mar 31Filed Apr 2 · 2d later

SEC filing

Director

Stock Equivalent UnitsGrant or award

Derivative units102$102.67 / derivative unit

$10.47K

Mar 31Filed Apr 2 · 2d later

SEC filing

Why this buying score?

Qualifying common-equity purchase value

$325,369 of common-equity purchase value after transaction-age decay across 180 days.

+12 pts

Distinct buying groups

3 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.

+5 pts

CFO purchase

Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.

+3 pts

Material reported holdings increase

At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.

+3 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0000001800
Latest public acceptance: Oct 2, 2026, 08:11 PM UTC
Score calculated: Oct 8, 2026, 12:02 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.